FDA Warning Letter — Hemarus LLC
The FDA took a Warning Letter action against Hemarus LLC on October 8, 2024 (Lauderhill, FL). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Hemarus LLC
- Date
- October 8, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Center
- CBER
- Location
- Lauderhill, FL (United States)